Provide for a Prime Contractor to establish and monitor a subcontractor network necessary to perform preclinical toxicology studies suitable for Investigational New Drug Application filing with the Food and Drug Administration.
| Conley, B A; Sewack, G F; Egorin, M J et al. (1991) The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide. Cancer Chemother Pharmacol 28:33-8 |
| Smith, A C; Liao, J T; Page, J G et al. (1989) Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Cancer Res 49:5385-91 |
| Smith, A C; Barrett, D; Stedham, M A et al. (1987) Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer. Cancer Treat Rep 71:1157-64 |
| Palmer, T E; Glaza, S M; Dickie, B C et al. (1985) Toxicity studies on the radioprotective agent WR-2721 in CDF1 mice and beagle dogs. Toxicol Pathol 13:58-65 |
